LB
64
2
CL
50
2
CB
50
2
HP
23
2
M
33
2
MAT
36
2
AON
45
2
NWS
94
2
CSCO
54
3
IFF
48
3
AEP
74
2
FFIV
64
-2
ECL
49
5
CINF
50
5
FITB
73
15
PBI
46
3
PH
70
3
FOXA
55
2
FIS
90
12
C
67
2
LB
64
2
CL
50
2
CB
50
2
HP
23
2
M
33
2
MAT
36
2
AON
45
2
NWS
94
2
CSCO
54
3
IFF
48
3
AEP
74
2
FFIV
64
-2
ECL
49
5
CINF
50
5
FITB
73
15
PBI
46
3
PH
70
3
FOXA
55
2
FIS
90
12
C
67
2
Financhill
Back

Cytokinetics Stock Price Chart

This Tech Company Grew 32,481%...

This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
Sell
25

CYTK
Cytokinetics

Last Price:
$41.27
Seasonality Move:
8.2%

7 Day Trial

ALL ACCESS PASS

$ 7
  • Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and CYTK is experiencing buying pressure, which is a positive indicator for future bullish movement.

Cytokinetics Price Chart Indicators

Moving Averages Level Buy or Sell
8-day SMA: 39.56 Buy
20-day SMA: 38.7 Buy
50-day SMA: 42.35 Sell
200-day SMA: 50 Sell
8-day EMA: 39.95 Buy
20-day EMA: 37.17 Buy
50-day EMA: 26.79 Buy
200-day EMA: 9.77 Buy

Cytokinetics Technical Analysis Indicators

Chart Indicators Level Buy or Sell
MACD (12, 26): 4.31 Buy
Relative Strength Index (14 RSI): 53.79 Buy
Chaikin Money Flow: 657497 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (37.17 - 41.91) Buy
Bollinger Bands (100): (41.03 - 49.43) Sell

Cytokinetics Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Technical Analysis for Cytokinetics Stock

Is Cytokinetics Stock a Buy?

  • Cytokinetics share price is 41.29 while CYTK 8-day simple moving average is 39.56, which is a Buy signal.
  • The stock price of CYTK is 41.29 while Cytokinetics 20-day SMA is 38.70, which makes it a Buy.
  • Cytokinetics 50-day simple moving average is 42.35 while CYTK share price is 41.29, making it a Sell technically.
  • CYTK stock price is 41.29 and Cytokinetics 200-day simple moving average is 50.00, creating a Sell signal.

CYTK Technical Analysis vs Fundamental Analysis

Sell
25
Cytokinetics (CYTK) is a Sell

Is Cytokinetics a Buy or a Sell?

  • Cytokinetics stock is rated a Sell
    The current Cytokinetics [CYTK] share price is $41.29. The Score for CYTK is 25, which is 50% below its historic median score of 50, and infers higher risk than normal.

Cytokinetics Stock Info

Market Cap:
4.9B
Price in USD:
41.29
Share Volume:
1.1M

Cytokinetics 52-Week Range

52-Week High:
68.44
52-Week Low:
32.74
Sell
25
Cytokinetics (CYTK) is a Sell

Cytokinetics Share Price Forecast

  • What is the Cytokinetics stock price today?
    The Cytokinetics stock price is 41.29 USD today.
  • Will CYTK stock go up or go down?
    Cytokinetics> share price is forecast to RISE/FALL based on technical indicators
  • Is Cytokinetics overvalued?
    According to simple moving average, exponential moving average, oscillators, and other technical indicators, Cytokinetics is overvalued.

Is Cytokinetics Stock a Buy?

  • Cytokinetics share price is 41.29 while CYTK 8-day exponential moving average is 39.95, which is a Buy signal.
  • The stock price of CYTK is 41.29 while Cytokinetics 20-day EMA is 37.17, which makes it a Buy.
  • Cytokinetics 50-day exponential moving average is 26.79 while CYTK share price is 41.29, making it a Buy technically.
  • CYTK stock price is 41.29 and Cytokinetics 200-day simple moving average is 9.77, creating a Buy signal.

Fundamental Analysis of Cytokinetics

Is Cytokinetics a good investment?

  • Analysts estimate an earnings decrease this quarter of $0.24 per share, an increase next quarter of $0.27 per share, a decrease this year of $0.48 per share, and an increase next year of $0.69 per share.

Technical Analysis of Cytokinetics

Should I short Cytokinetics stock?

* Cytokinetics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.